Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3–8 Years

Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3–8 Years

Two doses of the inactivated influenza vaccine (IIV) are generally recommended for children under 9 years old. This study assessed the necessity for a second dose of quadrivalent IIV (IIV4) in children aged 3–8 years. In this randomized, open-label, paralleled-controlled study, 400 children aged 3–8...

Full description

Bibliographic Details
Main Authors: Yunfeng Shi, Wanqi Yang, Xiaoyu Li, Kai Chu, Jianfeng Wang, Rong Tang, Li Xu, Lanshu Li, Yuansheng Hu, Chenyan Zhao, Hongxing Pan
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Vaccines
Subjects:
inactivated influenza vaccine
immunogenicity
safety
two-dose regimen in children
Online Access:https://www.mdpi.com/2076-393X/11/10/1586

Internet

https://www.mdpi.com/2076-393X/11/10/1586

Similar Items